INTESTINAL IMMUNE SYSTEM IN HOST-ENVIRONMENT INTERACTION
宿主与环境相互作用中的肠道免疫系统
基本信息
- 批准号:8011407
- 负责人:
- 金额:$ 10.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAnimal ModelBiological ModelsCell LineCell SeparationCell physiologyCellsCholera ToxinColonCommunicationDendritic CellsDiseaseEnteralEnvironmentEpithelial CellsEquilibriumFundingGastroenterologyGiardiaGoalsGranulocyte-Macrophage Colony-Stimulating FactorGuidelinesHistopathologyHomeostasisHypersensitivityImageImmuneImmune responseImmune systemImmunityImmunologyIn VitroInfectionInflammatoryInflammatory ResponseInstitutesIntestinal MucosaIntestinesLesionLinkMedicineMicrobeModelingMolecularMucosal Immune ResponsesMucositisMusNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNeurosciencesOutcomePathogenesisPathologyRegulationRegulatory T-LymphocyteResearchResearch PersonnelResearch Project GrantsRetinoidsRheumatologyRotavirusSignal PathwaySignal TransductionSmall IntestinesSmall intestine mucous membraneT-LymphocyteWorkacquired immunitybaseenteric pathogenexperienceimprovedin vivointerdisciplinary approachmedical schoolsmicrobialminimally invasivemouse modelnovelpathogenprogramsresponsetherapeutic target
项目摘要
DESCRIPTION, OVERALL (provided by applicant):
The central theme of the Program Project Is focused on mechanisms that determine innate and acquired immune responses in the intestinal mucosa to enteric microbes and microbial products, and the consequent mucosal protective immune and inflammatory responses. The four interrelated research projects specifically address the regulation of communication between epithelial cells and dendritic cells, and between dendritic cells and T cells, which takes place during mucosal homeostasis and protective immunity. Model enteric pathogens are used to probe mucosal cellular responses in novel in vivo and in vitro murine model systems. The program brings together experienced investigators from the Departments of Medicine, Pathology, and Neurosciences and the UCSD campus based La Jolla Institute for Allergy and Immunology. The investigators have a record of significant expertise in cellular and molecular mucosal immunology, mucosal inflammation, cell signaling and microbial pathogenesis, and a record of collaborative interactions. Research Unit 1 investigates the regulation of innate mucosal immune responses by dendritic cells (DC) and epithelial cells in the colon and small intestine. Unit 1 uses an attaching and effacing lesion-inducing enteric pathogen and rotavirus to probe the host response, and the mechanisms by which granulocyte-macrophage colony stimulating factor determines the outcome of enteric infection. Research Unit 2 investigates intestinal mucosal responses that determine immune defenses against minimally invasive enteric pathogens, using Giardia as a model protozoan pathogen that elicits strong protective immunity in the absence of mucosal inflammation. Research Unit 3 investigates how mucosal adjuvants override the tolerance-inducing effects of T regulatory cells and provoke effector T cell immune responses, with a focus on cholera toxin and Th17 differentiation in vitro and in vivo. Research Unit 4, which is new to the Program with the renewal application, investigates mechanisms by which retinoids determine the balance between normal mucosal homeostasis and protective immunity through their activity on DC and T cells. The research projects are supported by four Cores: a Mouse Model Core, a Histopathology Core, an Imaging and Cell Sorting Core and an Administrative Core.
总体描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin Frederick KAGNOFF其他文献
Martin Frederick KAGNOFF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin Frederick KAGNOFF', 18)}}的其他基金
Regulation of Innate Immunity to Enteric Infection
对肠道感染的先天免疫的调节
- 批准号:
7757152 - 财政年份:2009
- 资助金额:
$ 10.05万 - 项目类别:
IDENTIFYING PRESUMPTIVE CELIAC DISEASE IN HIGH RISK POPULATIONS
识别高危人群中的疑似乳糜泻
- 批准号:
8166883 - 财政年份:2009
- 资助金额:
$ 10.05万 - 项目类别:
Physiologic Functions of NF-kB Signaling in Intestinal Epithelium
肠上皮中 NF-kB 信号传导的生理功能
- 批准号:
7425090 - 财政年份:2007
- 资助金额:
$ 10.05万 - 项目类别:
CORE--MOUSE BREEDING AND INTESTINAL XENOGRAFT FACILITY
核心——小鼠饲养和肠道异种移植设施
- 批准号:
6580372 - 财政年份:2002
- 资助金额:
$ 10.05万 - 项目类别:
EPITHELIAL CELLS--SENSORS AT THE HOST MICCROBIAL INTERFACE
上皮细胞——宿主微生物界面上的传感器
- 批准号:
6580374 - 财政年份:2002
- 资助金额:
$ 10.05万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别: